EP Patent

EP2262506B1 — Low viscosity, highly flocculated triamcinolone acetonide suspensions for intravitreal injection

Assigned to Alcon Research LLC · Expires 2014-05-07 · 12y expired

What this patent protects

Patent listed against oxymetazoline-hydrochloride.

Drugs covered by this patent

oxymetazoline-hydrochloride (OXYMETAZOLINE HYDROCHLORIDE)

Patent Metadata

Patent number: EP2262506B1
Jurisdiction: EP
Classification: —
Expires: 2014-05-07
Drug substance claim: No
Drug product claim: No
Assignee: Alcon Research LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.